Patents by Inventor Yeun Ju Kim

Yeun Ju Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PD-L1/ANTI-LAG3 BISPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20220363763
    Abstract: The present disclosure provides an anti-PD-L1/anti-LAG3 bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between LAG3 and its ligand (e.g., a MHC class II molecule and FGL1). The bispecific antibody may have high binding affinity to both of a PD-L1 protein (e.g., a human PD-L1 protein) and a LAG3 protein (e.g., a human LAG3 protein). Also provided are antibodies and fragments that have specificity to the PD-L1 or LAG3 protein alone, or antibodies and fragments having additional specificity to one or more other antigens.
    Type: Application
    Filed: August 21, 2019
    Publication date: November 17, 2022
    Applicant: ABL BIO INC.
    Inventors: Eunyoung PARK, Yangsoon LEE, Uijung JUNG, YoungKwang KIM, Yeun Ju KIM, Youngdon PAK, Sang Hoon LEE, Weon-Kyoo YOU, Jaeho JUNG, Lei FANG, Wenqing JIANG
  • Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same
    Patent number: 10155817
    Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: December 18, 2018
    Assignee: PharmAbcine Inc.
    Inventors: Joong Kyu Kim, Jin San Yoo, Sang Hoon Lee, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim, Jin Sang Yoo, Young Ae Lee, Mi Ju Park, Sang Soon Byun, Hyuk Joon Lee, Do Yun Kim, Yeun Ju Kim, Jin Hee Choi, Kyung Hee Nahm, Ju Ryung Nam, Jong Geun Jeong, Bo Young Jeong, Eun Jin Lee, Seon Young Lee, In Sook Park, Jin Sook Lee, Jae Bong Yoon, Nam Ye Kim, Seon Hwan Oh
  • DUAL-TARGET ANTIBODY TARGETING VEGFR-2 AND DLL4, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
    Publication number: 20180208660
    Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
    Type: Application
    Filed: March 14, 2018
    Publication date: July 26, 2018
    Applicant: PharmAbcine Inc.
    Inventors: Joong Kyu Kim, Jin San Yoo, Sang Hoon Lee, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim, Jin Sang Yoo, Young Ae Lee, Mi Ju Park, Sang Soon Byun, Hyuk Joon Lee, Do Yun Kim, Yeun Ju Kim, Jin Hee Choi, Kyung Hee Nahm, Ju Ryung Nam, Jong Geun Jeong, Bo Young Jeong, Eun Jin Lee, Seon Young Lee, In Sook Park, Jin Sook Lee, Jae Bong Yoon, Nam Ye Kim, Seon Hwan Oh
  • Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same
    Patent number: 9963512
    Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: May 8, 2018
    Assignee: PharmAbcine Inc.
    Inventors: Joong Kyu Kim, Jin San Yoo, Sang Hoon Lee, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim, Jin Sang Yoo, Young Ae Lee, Mi Ju Park, Sang Soon Byun, Hyuk Joon Lee, Do Yun Kim, Yeun Ju Kim, Jin Hee Choi, Kyung Hee Nahm, Ju Ryung Nam, Jong Geun Jeong, Bo Young Jeong, Eun Jin Lee, Seon Young Lee, In Sook Park, Jin Sook Lee, Jae Bong Yoon, Nam Ye Kim, Seon Hwan Oh
  • DUAL-TARGET ANTIBODY TARGETING VEGFR-2 AND DLL4, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
    Publication number: 20150315277
    Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
    Type: Application
    Filed: November 20, 2013
    Publication date: November 5, 2015
    Applicant: PharmAbcine Inc.
    Inventors: Joong Kyu Kim, Jin San Yoo, Sang Hoon Lee, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim, Jin Sang Yoo, Young Ae Lee, Mi Ju Park, Sang Soon Byun, Hyuk Joon Lee, Do Yun Kim, Yeun Ju Kim, Jin Hee Choi, Kyung Hee Nahm, Ju Ryung Nam, Jong Geun Jeong, Bo Young Jeong, Eun Jin Lee, Seon Young Lee, In Sook Park, Jin Sook Lee, Jae Bong Yoon, Nam Ye Kim, Seon Hwan Oh